电生理设备市场规模、份额和成长分析：按类型、按适应症、按最终用途、按地区 - 产业预测，2024-2031 年

Electrophysiology Devices Market Size, Share, Growth Analysis, By Type, By Indication (Atrial Fibrillation, Non-Atrial Fibrillation), By End-Use, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球电生理设备市场规模为60.9亿美元，将从2023年的67.8亿美元成长到2031年的158亿美元，预计预测期内（2024-2031年）复合年增长率为11.16%。 1000万美元。

越来越多地采用电生理学 (EP) 测试来预防和治疗心房颤动 (AF) 等心臟病，这正在显着推动市场成长。由于持续监测的需要以及这些设备在非医院环境中的使用不断增加，对心律管理设备的需求正在迅速增加。久坐的生活方式、吸烟、过量饮酒和其他风险等因素正在增加心臟衰竭、心臟麻痹和心房颤动的发病率，尤其是在千禧世代。美国疾病管制与预防中心预测，到 2031 年，大约 1,210 万美国将受到心房颤动的影响。心房颤动在欧洲比其他地方更常见，欧洲心臟学会指出，心律不整导致的心臟麻痹是西方国家死亡的主要原因。每年大约有千分之一的人受到这种疾病的影响。由于心臟病患病率不断增加，电生理学设备对于心律不整的检测和治疗至关重要，因此越来越多地被使用。行动心臟监测和动态心电图 (ECG) 追踪的进步使得植入式心臟装置的远端监测和资料储存变得更加容易。这一趋势预计将进一步推动市场成长。此外，向冷冻消融、雷射治疗和超音波消融等微创手术的转变正在推动该领域的发展。例如，2022 年 2 月，美敦力公司的 Freezor 和 Freezor Xtra 心臟冷冻消融焦点导管获得 FDA核准，该导管旨在治疗儿科患者的房室结折返性心动过速 (AVNRT)。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Medtronic（Ireland）
Boston Scientific Corporation（US）
Abbott（US）
GE HealthCare（US）
Biotronik SE & Co. KG（Germany）
MicroPort Scientific Corporation（China）
Koninklijke Philips NV（Netherlands）
Siemens Healthineers（Germany）
CardioFocus Inc.（US）
LivaNova PLC（UK）
Penumbra, Inc.（US）
Stereotaxis, Inc.（US）
Advanced Cardiac Therapeutics, Inc.（US）
CathRx Ltd.（Australia）
Osypka Medical GmbH（Germany）
AngioDynamics, Inc.（US）
H2O.ai Inc.（US）
DataRobot, Inc.（US）
Clarifai, Inc.（US）
Darktrace plc（UK）
C3.ai, Inc.（US）

简介目录

Product Code: SQMIG35A2420

Global Electrophysiology Devices Market size was valued at USD 6.09 billion in 2022 and is poised to grow from USD 6.78 billion in 2023 to USD 15.81 billion by 2031, at a CAGR 11.16 % during the forecast period (2024-2031).

The rising adoption of electrophysiology (EP) tests for both preventing and treating heart conditions like atrial fibrillation (AF) is significantly driving market growth. The demand for cardiac rhythm management equipment has surged due to the need for continuous monitoring and the increasing use of these devices in non-hospital environments. Factors such as sedentary lifestyles, smoking, excessive alcohol consumption, and other risks are contributing to higher incidences of heart failure, sudden cardiac arrest, and AF, particularly among millennials. The Centers for Disease Control and Prevention projects that approximately 12.1 million Americans will be affected by AF by 2031. In Europe, atrial fibrillation is more common than in other regions, with the European Society of Cardiology noting that sudden cardiac arrest due to irregular heart rhythms is a leading cause of death in Western countries. Annually, around one in every 1,000 people is impacted by this condition. Electrophysiology devices, essential for detecting and managing heart arrhythmias, are seeing increased usage due to the growing prevalence of heart disease. The advancements in mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking are making remote monitoring of implanted cardiac devices and data storage more accessible. This trend is expected to further propel market growth. Moreover, the shift towards minimally invasive procedures, such as cryoablation, laser therapy, and ultrasonic ablation, is enhancing the sector's development. For instance, in February 2022, Medtronic received FDA approval for the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters, designed for managing Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophysiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophysiology Devices Market Segmental Analysis

The global electrophysiology device market is segmented based on Product, indication, end-use, and region. Based on type, the market is segmented into Ablation Catheters [Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation], Diagnostic Catheter, Laboratory Devices, Access Devices. Based on indication, the market is segmented into Atrial fibrillation, and Non-Atrial Fibrillation. Based on end-use the market is segmented into Inpatient Facilities, Outpatient Facilities, and Others. Based on region the global Electrophysiology Devices Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is significantly driving the demand for electrophysiology devices. Accurate diagnosis and effective treatment of these conditions are crucial, and electrophysiological devices play a vital role in addressing these needs. As the prevalence of these arrhythmias rises, the reliance on advanced electrophysiology devices for precise diagnosis and management grows. These devices are essential for both detecting and treating complex cardiac irregularities, further boosting their market demand.

Restraints in the Global Electrophysiology Devices Market

The high cost of electrophysiology devices can be a significant barrier to their widespread adoption, especially in areas with constrained healthcare budgets or stringent reimbursement policies. This financial constraint often limits access to these advanced technologies in less affluent regions or healthcare systems with restrictive funding. Due to their expense, the market for electrophysiology devices faces challenges related to affordability and accessibility. The substantial investment required for these devices can restrict their use, particularly in settings where budget limitations or stringent reimbursement policies are prevalent.

Market Trends of the Global Electrophysiology Devices Market

The field of electrophysiology is increasingly leaning towards minimally invasive procedures. Technological advancements and innovations in device design have led to the development of catheter-based techniques that offer precise diagnosis and treatment of cardiac arrhythmias, all while minimizing patient discomfort. These advanced techniques contribute to shorter recovery periods and a reduced risk of complications. By focusing on minimally invasive approaches, the field aims to enhance patient outcomes and streamline the overall treatment process.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Value Chain Analysis
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Porter's Five Forces Analysis
Patent Analysis
Pricing Analysis
Technology Analysis
Raw Material Analysis
Supply Chain Analysis

Global Electrophysiology Devices Market by Type

Market Overview
Ablation Catheters
- Radiofrequency (RF)Ablation
- Cryoablation, Pulse Field Ablation
Diagnostic Catheter
Laboratory Devices
Access Devices

Global Electrophysiology Devices Market by Indication

Market Overview
Atrial fibrillation
Non-Atrial Fibrillation

Global Electrophysiology Devices Market by End User

Market Overview
Inpatient Facilities
Outpatient Facilities
Others

Global Electrophysiology Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioFocus Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stereotaxis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Cardiac Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CathRx Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka Medical GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H2O.ai Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DataRobot, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clarifai, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Darktrace plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C3.ai, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments